Hoolaha

[30] [New] Analytical Performance Evaluation of Goldstream Fungus (1-3)-β-D Glucan

[29] Ka loiloi o kahi Cryptococcus capsular polysaccharide detection FungiXpert LFA no ka hōʻoia wikiwiki o Cryptococcosis

[28] ʻO ka Waiwai Diagnostic o ka mea hana ʻakomi piha no ka (1-3) -β-d-glucan hoʻāʻo i nā maʻi me ka tumor.

[27] Ka Loiloi Hana Hana Ola o kahi Novel Monotest Glactomannan Detection i ka Ma'i o Invasive Aspergillosis

[26] Ka noiʻi ʻana i ka hana diagnostic o kekahi mau ʻano hana Galactomannan like ʻole no ka Aspergillosis Invasive.

[25] Hoʻopili ʻia ʻo Lateral Flow Analysis me Immunochromatofraphy Analyzer no ka GM Quantative Detection

[24] Ka hoʻohālikelike ʻana o nā kaʻina hana microbiological ʻokoʻa no ka ʻike ʻana o ka Pneumocystis jirovecii pneumonia ma ka bronchoalveolar-lavage fuid

[23] ʻO ka mālama ʻole ʻana i ka ʻokoʻa ʻokoʻa e pale i ka hōʻoia ʻana o ka Cryptococcus Infec(2)

[22] Ka loiloi o Carbapenem-Resistant KNIVO Detection K-Set no ka ʻike wikiwiki ʻana i nā carbapenemases ma waena o ka carbapenem-resistant gram-negative bacilli

[21] ʻO ke koʻikoʻi o ka ʻike hui ʻana o Candida mannan a me ka antibody lateral flow assay for invasive candidiasis diagnostic.

[20] ʻO ke koʻikoʻi o ka ʻike hui ʻana o Aspergillus antigen a me ka antibody lateral flow assay for invasive pulmonary aspergillosis diagnostic.

[19] ʻO ke ʻano Diagnostic Novel no ka maʻi fungal - (1,3)-β-D-Glucan Chemiluminescence Immunoassay

[18] Pūnaehana Immunoassay Kemiluminescence piha no ka ʻike ʻana iā Aspergillus Galactomannan.

[17] Ka pololei o ka diagnostics o ka serum 1,3-β-D-glucan no ka pneumocystis jiroveci pneumonia, invasive candidiasis, a me ka invasive aspergillosis systematic review and meta-analysis

[15] ʻO nā kumu pilikia no ka hoʻi hou ʻana o ka maʻi fungal invasive i ka wā o ka prophylaxis antifungal kiʻekiʻe i ka allogeneic hematopoietic stem cell transplant recipients.

[14] ʻO ka pae serum glucan a me nā loli pathological o ka mālama antifungal no ka maʻi ʻeha haʻahaʻa o Candida albicans

[13] Ka Loiloi o kahi Novel Plasma (1,3)-β-d-Glucan Detection Assay for Diagnosis of Candidemia in Pediatric Patients

[12] Nā Palena Platelet a me (1, 3)-β-D-Glucan ma ke ʻano he Diagnostic and Prognostic Marker of Invasive Fungal Disease in Preterm Infants

[11] Ka Hana Screening o Serum 1,3-Beta-D-Glucan i nā poʻe maʻi me nā maʻi fungal invasive He Meta-Analysis of Prospective Cohort Studies

[10] ʻO nā pae Serum o Lipopolysaccharide a me 1,3-β-D-Glucan e pili ana i ke koʻikoʻi o nā maʻi me ka maʻi o Crohn.

[9] Ka puka ʻana o TR46 Y121F T289A i loko o kahi Aspergillus fumigatus Isolate mai kahi maʻi Kina.

[8] loiloi loiloi o Tachypleus amoebocyte lysate no ka ʻike mua ʻana o ka maʻi fungal invasive ma kahi ICU ma Kina

[6] Ka Hana Maʻi Maʻi o ka (1–3)-β-D-Glucan Assay i ka Pneumocystitis jirovecii, Invasive Aspergillosis, Mucormycosis, Tuberculosis a me nā Volunteers Healthy

[5] ʻO ka hana diagnostic o ka (1-3) -β-Dglucan assay i nā maʻi me Pneumocystis

[4] VALUTAZIONE DI UN NUOVO TEST GOLDSTREAM FUNGUS (1,3)-ß-D-Glucano PER LA DIAGNOSTICA DELLE INFEZIONI FUNGINE INVASIVE

[3] VALUTAZIONE DI DUE METODICHE PER IL DOSAGGIO SIERICO DEL 1,3-β-D-GLUCANO IN PAZIENTI A RISCHIO DI INFEZIONI FUNGINE INVASIVE

[2] Ka loiloi o CrAg lateral flow immunoassay no ka hōʻoia ʻana o nā maʻi maʻi maʻi cryptococcal

[1] Nā waiwai prognostic o serum galactomannan a me (1-3)-beta-D-glucan i loko o nā maʻi maʻi i ka nānā ʻana i nā hopena mua a me nā hopena hope.